NIH and NIDCR Advance First-in-Human Trial for Ultra-Rare Jansen's Disease Therapy

NIDCR prepares a first-in-human trial for Jansen’s disease, advancing a potential therapy for this ultra-rare skeletal disorder through NIH collaboration.